title: Locally advanced nasopharyngeal carcinoma: Current and emerging treatment strategies.
abstract: Although nasopharyngeal carcinoma (NPC) is a widespread malignant tumor, it is particularly frequent in Southeast Asia. Although T1 tumors can be effectively controlled with exclusive radiotherapy, this treatment modality is insufficient for most NPC patients, who present with locally advanced disease at diagnosis. In fact, for stages ranging from T2b N0 to T4 N3, definitive scientific evidence supports the use of concurrent platinum-based chemotherapy with standard external beam radiotherapy. This treatment approach has shown a statistically significant advantage in terms of overall survival, with respect to radiotherapy alone. Several trials have also investigated the use of neoadjuvant and adjuvant chemotherapy in combination with radiotherapy or chemo-radiotherapy. Platinum compounds, anthracyclines and taxanes are among the chemotherapy agents employed. This review focuses on the clinical results obtained in the field of adjuvant/concurrent/neoadjuvant chemotherapy for locally advanced NPC, for which exclusive concurrent chemo-radiotherapy currently represents the standard treatment approach.
authors.affiliation: Francesco Perri, Oncology Division, Division INT Fondazione "G. Pascale", 80131 Naples, Italy.
authors.forename: Francesco
authors.initials: F
authors.lastname: Perri
authors.forename: Davide
authors.initials: D
authors.lastname: Bosso
authors.forename: Carlo
authors.initials: C
authors.lastname: Buonerba
authors.forename: Giuseppe Di
authors.initials: GD
authors.lastname: Lorenzo
authors.forename: Giuseppina Della Vittoria
authors.initials: GD
authors.lastname: Scarpati